EriVan Bio is a biotechnology company, established to innovate and deliver products and services related to exosome technology for molecular and cell biology research and therapeutic purposes, particularly regenerative medicine and cancer treatment. EriVan Bio is focused on the development of a broad pipeline of novel and targeted biomolecules to address different unmet medical needs.
EriVan Bio works mainly in the therapeutic and drug development field and on exosome-based diagnostics to develop exosome-based tests and assays for unmet medical needs. Moreover, there is a potential for exosomes to be used as targeted delivery vehicles of therapeutic molecules to cancer cells, for example, delivering a small interfering RNA specific for a particular oncogene expressed in a tumor cell. Research tools for exosome detection and isolation constitute another field of expertise and development.